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Antisolvent addition at extreme conditions  
Martin R. Ward,*a Iain D.H. Oswalda 
This article describes the use of antisolvent addition at high-pressure to aid precipitation and recovery of high-pressure 
phases to ambient pressure. Paracetamol (PCM) was used as a model system to demonstrate the principle due to the 
extensive literature of paracetamol at high-pressure and ambient pressure. We have observed that we are able to recover 
the orthorhombic form of paracetamol to ambient pressure using this technique, although solvent-mediated 
transformations are a hurdle. During this investigation we observed a  new methanol solvate of paracetamol that is simlar 
in structure to the known form.  The methanol solvate is stable to 0.2 GPa before transformation to the orthorhombic form 
that is known to be the stable form at high pressure.
Introduction 
Exploring the solid-state landscape and the discovery of new 
solid forms is a continual challenge in the field of solid-state 
science.  The motivation behind this is that a new or alternative 
solid form, even polymorphs, can display markedly different 
physical properties.  The objective of tuning physical properties 
of a material is of particular importance in the pharmaceutical 
industry where deriving a new form of a drug can provide 
improved properties for processing or improved solubility e.g. 
Form II of paracetamol (PCM) compared to Form I (that is 
typically produced at ambient conditions). 
High-pressure studies have been shown to be a highly effective 
route to the discovery of new polymorphs,1,2 the observation of 
metastable solid forms;3 and the relative stability of polymorphs 
at pressure and in presence of seeds.4 The role of kinetic 
transformations between polymorphs of materials have been 
explored in serine5 and chlorpropamide.4 Chemical 
transformations and reactions have been explored such as 
dehydration6 or polymerisation.7–10  Traditionally, these studies 
utilise a diamond anvil cell (DAC) to provide a high-pressure 
environment (~0.1-100’s GPa) with the sample crystal 
monitored by single crystal X-ray diffraction (SC-XRD) during 
compression/decompression.11–14  
Alternatively, the DAC has also been used to perform 
crystallization at high-pressure by loading a solution sample and 
taking advantage of a typical decrease in solute solubility as 
pressure is increased.15,16  By this method crystal formation 
occurs at high-pressure conditions rather than inducing a solid-
state transformation by the application of pressure.  For a 
number of systems, the process of in-situ nucleation under 
high-pressure conditions has been shown to provide access to a 
high-pressure solid phase at significantly lower pressures than 
required to observe the pressure-induced transformation to a 
high pressure form.3,17,18 Due to the dimensions of the sample 
chamber (ca. 200 µm diameter, 90 µm thick) in the DAC 
assembly, these studies are limited by the quantity of 
crystallised solute and rely on spectroscopy (in-house), powder 
X-ray diffraction at synchrotron facilities or single crystal 
measurements through annealing of the powder into a single 
crystal. Attempts to recover phases have been made 
successfully and used to seed ambient pressure 
crystallisations.19,20  
High-pressure studies can be performed in significantly 
greater volumes using a large volume press (LVP) assembly.  
Rather than single crystal quantities of materials, the LVP can 
accommodate 100’s-1000’s mg sample.3,10,20 A drawback of the 
LVP is that the sample chamber is completely enclosed during 
the experiment and therefore restricts analysis of the sample to 
ex-situ measurements in a home laboratory.  Larger volumes 
can be accommodated on the beamline at Central Facilities 
using the Paris-Edinburgh press21,22 and these have been used 
successfully to explore molecular systems to high-pressure on a 
larger scale.10,23–29  
In the present work, (see Table S4) we have selected the 
model system of paracetamol to investigate use of antisolvent 
addition crystallization at high-pressure conditions. Successful 
demonstration of antisolvent addition at high-pressure would 
present a new approach to solid form discovery at extreme 
conditions and would hopefully stimulate further interest in the 
use of high-pressure methods for solid form discovery. 
Methods 
Paracetamol solutions 
To ensure sufficient solids were precipitated during an 
antisolvent addition crystallization, a solvent system was 
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selected with high solubility of PCM that also decreases rapidly 
with the addition of the anti-solvent.  In addition to this 
criterion, the solubility of the PCM with pressure was a 
consideration as we did not want the solution to precipitate out 
with pressure alone. To assess this, we applied pressure to three 
different concentrations of solution, 0.05, 0.1 and 0.2 g/g 
PCM/solvent. Based on the solubility determinations of PCM in 
binary aqueous solvent systems by Ó’Ciardhá C et. al.30 a 
mixture of Methanol:water (MeOH:H2O)(64 % w/w MeOH) was 
selected for this work. For high-pressure antisolvent addition 
experiments the same sample concentrations were prepared.  
Paracetamol was purchased from Sigma Aldrich (Sigma BioExtra 
≥ 99.0%, A7085) and used as received.  An appropriate amount 
of PCM was weighed out in to a 100 mL duran bottle to which a 
corresponding amount of solvent mixture was added.  
Complete dissolution was ensured by sonication of the sample 
bottle in a warm (40 °C) water bath with the samples allowed to 
cool back to room temperature before further use. 
Diamond Anvil Cell  
A Merrill-Bassett Diamond anvil cell was used for the initial 
screening of the precipitation process from solution. Gem 
quality diamonds with 600 µm culets were used together with 
a piece of tungsten foil with a 250 µm hole to serve as the 
sample chamber. Pressure measurements were made using the 
ruby fluorescence method.31 In three different experiments, 
solutions of 0.05, 0.10 and 0.20 g/g PCM/solvent were added to 
the DAC and sealed before applying pressure. In each 
experiment, ~0.8 GPa of pressure was applied to the solution 
(maximum pressure of Large Volume Press) and the sample left 
at this pressure for ca 2 hours; this was to address the challenge 
of pressure-induced nucleation. For all tested concentrations, 
no precipitation was observed on compression to 0.8 GPa nor 
over a timescale of at least 2 hours with some samples 
monitored for longer periods (0.05g/g 48 hours). Whilst the size 
of the chamber in the DAC is very much smaller than the large 
volume press, this was the only method by which the 
precipitation could be viewed microscopically hence allowing us 
to mitigate the chance of precipitation with pressure alone. 
Large volume press 
High-pressure conditions were provided by use of a large 
volume press assembly.  The sample chamber comprised a PTFE 
tube (ID = 8.0 mm, OD = 10.0 mm) sealed using PTFE end caps 
and PTFE sealing tape.20 
The axial compression of the PTFE sample tube during 
compression (reduction in length) was tested and recorded by 
video monitoring. The sample chamber was filled with 
MeOH:H2O mixture (64:36 w/w) and load applied to the cell 
incrementally up to a maximum load of 7-ton (equivalent 
sample pressure ca 0.8 GPa).  An identifiable mark was placed 
on the pneumatic actuator of the press at the relative position 
and monitored during compression using a Basler acA1920—
40uc camera and zoom lens assembly.  This information allowed 
calculation of the length of the PTFE sample tube as a function 
of applied load hence sample pressure. 
For anti-solvent addition, water was used as the antisolvent 
during this work.  A glass ampoule was flame sealed at one end 
and then filled with deionized water (approx. 1 mL, 18 MΩ cm-
1) before sealing the other end with epoxy glue.  The glue was 
allowed to fully cure and harden before further use.  To assist 
with breakage of the antisolvent tube, the walls were scored 
around its diameter using a ceramic cutting blade at three 
positions, equidistant, along the tube.  The sealed antisolvent 
tube was placed in the PTFE sample tube before filling the 
remaining volume of the PTFE tube with the paracetamol 
solution and sealing into the high-pressure cell.  Samples were 
taken to ca. 0.8 GPa and held at this pressure for approx. 20 
minutes.  Mixing in the sample chamber was promoted by 
manually rotating/inverting the high-pressure cell assembly 
before downloading back to ambient pressure. Any solids 
produced were isolated by filtration before further analysis by 
Raman spectroscopy or single crystal X-ray diffraction. 
Gravimetric solubility determination 
The solubility of PCM in 64% w/w aqueous MeOH solution at 
the experimental temperature (Room temperature, 20 °C) was 
determined using gravimetric methods.  A solution was 
prepared with excess PCM in the aqueous MeOH mixture and 
sealed to equilibrate over 24 hours at 20 °C.  Once saturated, 
the solution was syringe filtered (Millex-GP, 0.22 µm) into pre-
weighed vials that were maintained at 20 °C.  Samples were 
loosely covered to prevent ingress of contaminants and to allow 
loss of solvent through evaporation.  Samples were held at a 
temperature of 20 °C for 8 days before recording vial masses.  
Masses were subsequently recorded daily to ensure samples 
were fully dry.  Recorded masses stabilised after day 10 of 
evaporation/drying.  All weighing was performed using a 
Mettler Toledo AG204 analytical balance. 
Single crystal X-ray diffraction 
Ambient pressure 
Single crystal X-ray diffraction (SC-XRD) data were obtained 
using a Bruker D8 venture diffractometer equipped with a 
Photon 100 detector and Incoatec microfocus Cu X-ray source 
(Kα1, λ = 1.5406 Å).  Data were collected and reduced using 
Bruker Apex3 software.  Resolved structures were solved by 
intrinsic phasing using SHELXT using Olex232 (v1.2) software.  
Full-matrix least-squares refinement of data was performed 
with SHELXL using Olex2 software.  All non-hydrogen atoms 
were treated anisotropically.  Hydrogen atoms were placed on 
the carbon atoms and allowed to ride on their parent atoms. 
 
High pressure  
SC-XRD data were obtained using a Bruker Apex II 
diffractometer equipped with an Incoatec microfocus Mo X-ray 
source (Kα1, λ = 0.71073 Å). Data were reduced using Bruker 
Apex3 software. During the processing of data, it was apparent 
that the unit cell dimensions (from all three experiments, 0.05, 
0.1, 0.2 g/g) were different to those of the paracetamol33 and 
paracetamol:methanolate.34 The structure was solved by 
intrinsic phasing using SHELXT using Olex232 (v1.2) software and 
the coordinates were subsequently used for each high pressure 
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dataset.  Full-matrix least-squares refinement of data was 
performed with SHELXL using Olex2 software.  All non-hydrogen 
atoms were treated isotropically due to the paucity of data 
available from the sample in the diamond anvil cell.  The phenyl 
groups were constrained to be hexagons and the hydrogen 
atoms were placed on the carbon atoms and allowed to ride on 
their parent atoms. The hydroxyl hydrogen atoms were ideally 
placed on the oxygen atoms and allowed to ride. 
 The solved structure possessed three molecules of 
paracetamol and three molecules of methanol.  Structural 
comparison with the known methanol solvate (Rint ~5%; R-
factor 13.4%)34 in the database using the packing similarity 
search in Mercury showed that all 15 molecules were aligned to 
one another giving a root mean square deviation of 0.551.35 The 
similarity in structure forced a significant interrogation of our 
data to ensure that the correct unit cell and space group were 
assigned. Through combinations of brute force identification of 
unit cell (cell_now36) together with close inspection of the 
diffraction data we were unable to identify a cell that matched 
the previous work. Integration of potential cells (with similar 
dimensions to the methanolate) resulted in very poor 
integrations for those unit cell choices. The reduced data from 
the previous study was provided to us as a private 
communication but unfortunately the raw frames were not 
present. From the reduced data and the list files from this 
experiment it was clear that the choice of cell by the authors 
was correct. With our interrogation and the knowledge of the 
previous work we believe that this is another very similar 
polymorph of the solvate isolated from a different medium. We 
have used aqueous media in this study so this may be having a 
nuanced effect on the polymorphism. The data are deposited at 
the University of Strathclyde KnowledgeBase indicated in the 
acknowledgements.  
X-ray powder diffraction 
X-ray powder diffraction (XRPD) measurements were 
performed on a Bruker D8 Advance II diffractometer configured 
in Debye-Scherrer transmission geometry.  The diffractometer 
was equipped with a multiwell stage with a single layer of 
Kapton film to contain the samples.  X-ray emission was 
provided by a Cu source (λ = 1.5406Å) used in conjunction with 
a Kα1 Johansson monochromator and 1 mm anti-divergence 
slit.  A Vantec 1D detector was used together with 2.5° Soller 
slits.  All data was collected at room temperature without 
grinding the sample material.  Simple Pawley fitting and 
Rietveld refinement of the XRPD data was performed using 
Topas (Academic, V5).37 
Raman spectroscopy 
A Horiba Xplora Raman microscope equipped with a 532 nm 
laser source was used for the collection of Raman spectra.  Slit, 
Hole, Filters and accumulation times were varied to maximise 
the sample signal and reduce any fluorescence that may have 
come from the sample environment, however final spectra 
were the sum of 2 accumulations to account for any transitory 
events. 
UV-vis spectroscopy 
UV-vis spectra were collected using a Jenway Genova Nano UV-
vis spectrophotometer.  Spectra were recorded over 200-400 
nm with resolution of 2 nm.  Concentrated PCM solutions were 
diluted with aqueous MeOH (64% w/w MeOH) by a factor of 
8000 to provide a suitable signal over the concentration range 
of samples tested.  A calibration curve was constructed using 
solutions of known concentrations (0.14, 0.18, 0.20, 0.22 and 
0.24 g/g solute/solvent).  Sample solutions were then tested 
following the same experimental procedure and dilution factor 
with all measurements made in triplicate. 
Results and Discussion 
Large volume press tests 
We tested a range of solutions (0.10-0.22 g/g) in the large 
volume press without the addition of the antisolvent to observe 
whether the PCM precipitated from solution and was 
recoverable to ambient pressure without the use of the 
antisolvent. During these experiments, we noted that samples 
appeared to undergo a phase separation and showed a clear 
boundary between two colourless liquid phases inside the PTFE 
sample tube on recovery to ambient pressure. The phase 
separation was clearly visible when we inverted the sample 
tubes. We performed UV experiments on the upper portion of 
the liquid to calculate its PCM concentration (Table 1). The 
upper layer of the liquid demonstrates a lower concentration of 
the solution verifying the visual evidence.  Our explanation for 
this is that over this pressure range the paracetamol 
precipitates from solution and the solid falls to the bottom of 
the tube. On decompression to ambient pressure, the 
precipitate dissolves leading to an apparent liquid/liquid phase 
separation with a more concentrated solution at the bottom of 
the tube. Extrapolating this data to lower concentrations allows 
us to estimate that at 0.05 g/g PCM/solvent, there would be no 
precipitation at all from direct compression of the solution 
hence would be ideal to test the antisolvent addition. 
Table 1.  Summary of UV-vis measurements made on 200 µL aliquots of the upper layer 
observed following compression of sample solutions to ca 0.8 GPa pressures 
Solution 
concentration  
(g/g solvent) 
Mean 
absorbance  
(248 nm) 
Calculated 
concentration 
(g/g solvent) 
% difference to 
expected 
concentration 
0.14 0.302 0.048 66.0 
0.16 0.446 0.070 56.1 
0.18 0.631 0.099 44.9 
0.20 0.682 0.107 46.4 
0.22 0.973 0.153 30.4 
 
Large volume press – antisolvent addition 
Anti-solvent addition experiments were performed using water 
as the antisolvent and an aqueous solution of MeOH (64% 
MeOH w/w) as the solvent phase.  We selected this system 
based on reported solubility data for PCM that demonstrated 
both good solubility (ca 100’s mg/g solvent) and a significant 
rate of change of solubility with increasing water content that 
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would maximise the precipitation of PCM for a given amount of 
antisolvent delivered to the solution phase. 
We used a glass ampoule filled with water to add the 
antisolvent to the solution. Through systematic evaluation of 
the compression length in the press we designed the ampoule 
to break at the point where the target sample pressure was 
reached, e.g. 0.8 GPa.   The nature of the equipment (Copper-
Beryllium cell) prevented us from observing the successful 
breakage of the glass ampoule until the end of the experiment 
when the sample cell was brought back to ambient pressure.  In 
spite of this, it was found that breakage of the antisolvent 
ampoule was very reproducible and occurred 9/11 attempts.  
For each sample that saw breakage of the glass ampoule, 
crystallization had occurred with the solids recoverable back to 
ambient pressure when downloaded. The amount of 
crystallized material would vary from sample to sample that is 
likely a result of the way in which the antisolvent ampoule had 
broken and the amount of mixing of the solution and 
antisolvent that had occurred within the cell. Typically, we 
observed crystals at the bottom of the PTFE tube and within 
broken fragments of the antisolvent ampoule.  We were able to 
isolate the crystals from the sample for imaging, Raman 
spectroscopy and SC-XRD. Samples isolated by filtration would 
yield between 50-200 mg of material.  
A number of particles were tested by Raman spectroscopy 
to assess the crystal forms present at each location in the 
sample i.e. the bottom of the PTFE capsule or in the ampoule.  
Differentiation of the Form I, II polymorphs by Raman 
spectroscopy was performed by monitoring characteristic 
peaks38 over the range 400-525 cm-1 e.g. 454, 465 and 504 cm-1. 
Raman spectra collected for crystals found at the bottom of the 
PTFE tube and within broken glass fragments during LVP 
experiments are shown in Figure 1. Crystals that were 
recovered from inside the fractured glass antisolvent tube were 
found to be exclusively Form I PCM.  In contrast, crystals 
samples from the bottom of the PTFE tube were found to be a 
mixture of Form I and II PCM.  It is noted, however, that crystals 
within the broken fragments of glass were difficult to isolate 
from the solution phase due to contact with the glass 
fragments.  These particles could not be readily filtered and 
remained in contact with the solution phase for longer, 
therefore these particles have an increased likelihood of 
solution-mediated transformation to PCM I. 
Figure 1.  Raman spectra for crystals obtained during antisolvent addition in a large 
volume press.  The spectra for crystals collected from the bottom of the PTFE 
sample tube (lower, red) are consistent with Form II paracetamol.  The spectrum 
collected for Form I crystals found within the fractured antisolvent ampoule is also 
shown for reference (upper, black) 
A microscope image is shown in Figure 2a and comprises a 
mixture of well-defined particles of distinct morphologies; the 
image was collected approximately 30 minutes after the sample 
was brought back to ambient pressure. Two distinct 
morphologies are seen throughout the sample mixture - long 
rods and blocks.  These morphologies are those expected for 
Form II and Form I PCM, respectively.   
Figure 2: a) Microscopy images of the crystals from the LVP experiments after 
recovery to ambient pressure showing a mixture of Form I and II PCM crystals.  b) 
The ampoules of PCM solution and antisolvent before (left) and after (right) 
compression indicating the fracture of the ampoule and crystallisation of PCM. c) 
The Rietveld fit of PCMI and PCM II to the data from the crystals recovered from 
the antisolvent high-pressure experiment indicating a mixed phase. 
The composition of the crystallized product was tested using 
XRPD. We rapidly isolated the product through filtration 
(approx. 10 minutes after download to ambient pressure) 
before collection of XRPD data.  Initially, we emptied the 
contents on to a filter paper for isolation with all visible 
fragments of broken glass removed before XRD analysis.  The 
sample w as collected repeatedly (5 times, 35 min per 
collection) over 3 hours to assess how stable the sample 
mixture was.  Over the 3-hour period, the XRPD pattern 
remained unchanged and therefore it was established that 
filtration was sufficient to limit further solid form 
transformation. A rigid body Rietveld refinement of the XRPD 
data was performed using reference structures from the CSD 
(HXACAN04 and HXACAN08), confirming a mixture of Form I 
and II of PCM with an approximate relative composition of 58% 
Form II and 42% Form I (Figure 2c). 
Table 2.  Summary of data obtained from single-crystal X-ray diffraction on a Form II PCM 
particle obtained through antisolvent addition at high-pressure. 
Crystal system, space group Orthorhombic, Pbca 
Temperature (K) 296 
a, b, c (Å) 17.1522 (5), 11.8201 (4), 7.3985 (2) 
V (Å3) 1499.98 (8) 
Z 8 
Radiation type Cu Kα (λ = 1. 540596 Å) 
Rint 0.038 
(sin θ/λ)max (Å-1) 0.603 
R[F2 > 2σ(F2)], wR(F2), S 0.045,  0.122,  1.07 
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We analysed single crystals removed from the sample tube (and 
ampoule fragments) using single crystal X-ray diffraction to 
confirm the solid form indicated by initial Raman spectroscopy.  
All crystals removed from the broken ampoule fragments 
indexed with unit cell parameters consistent with Form I PCM.  
Numerous crystals retrieved from the bottom of the PTFE tube 
were also indexed that indicated a mixture of crystals that 
indexed with unit cell parameters consistent with Form I and 
Form II PCM.  These observations are in line with the results 
obtained from Raman spectroscopy measurements on crystals 
isolated from these distinct regions within the sample cell. The 
quality of the crystals isolated via this technique is 
demonstrated by a full collection on a Form II crystal (Table 2.  
Summary of data obtained from single-crystal X-ray diffraction 
on a Form II PCM particle obtained through antisolvent addition 
at high-pressure.). 
Mixed phase 
The presence of the mixed phase in the tubes is concerning for 
the control of polymorphism. The formation of Form II PCM may 
be a direct result of nucleation at elevated pressure.  
Experiments performed in DAC have reported in-situ nucleation 
of PCM form II from acetone, dioxane and water solutions at 
pressures below those achieved during these experiments (~0.4 
GPa).3  Additionally, paracetamol forms a methanol solvate at 
~0.6 GPa that may be applicable in this experiment. It is 
therefore implied that if anti-solvent addition occurs around 0.8 
GPa, the resulting product could be Form II PCM or the 
methanol solvate. Form I PCM produced during these 
experiments may then result from anti-solvent/solution mixing 
that occurs during decompression. The potential for solvent 
mediated transformation of Form II Form I PCM is possible 
and FBRM measurements have been used to study the solution 
mediated transformation of Form II  Form I PCM in 
EtOH:MeOH (95:5 v/v) solution in work by Barthe and Grover.39  
Their results showed a rapid transformation over a period of 
minutes with an apparent complete conversion taking place 
over a time period ca. 1 hour.  In our work, the decompression 
to ambient pressure and recovery of the crystals for analysis 
requires approximately 10-20 minutes to complete and 
therefore it is likely that at least some degree of solution 
mediated transformation of Form II  Form I PCM has occurred 
prior to sample analysis.  During microscopy of a sample 
prepared during this study a series of images were recorded 
over a 30-minute period with the crystals in contact with the 
solution phase that showed the growth of Form I crystals at the 
expense of Form II crystals that dissolved back in to solution.  
These crystals were first imaged approximately 30 minutes after 
download back to ambient pressure and then monitored for a 
further 30 minutes (Figure S4).  Problems associated with 
recovery of PCM II back to ambient pressure have also been 
reported by Oswald et al where it was found that cooling the 
sample to 275-280 K significantly reduced the rate of solution 
mediated transformation to PCM I.3 In the present work, cooling 
of the sample chamber during compression/decompression in 
the home laboratory was not a viable option.  As an alternative, 
one test was performed in which 0.5 mL of perfluorinated oil 
(Perfluoropolyether fluid, Galden SV110, Solvay, Italy) was 
included in the PTFE tube before filling with PCM solution.  On 
download back to ambient pressure, the sample had crystallized 
and the resultant solids were isolated at the interface between 
the oil and solution phases.  Rietveld refinement of the XRPD 
data indicate an increased proportion (65%) of PCM II in the 
sample mixture when using oil compared to without oil (58 %). 
This is taken as an indication of the role of solution mediated 
transformation of PCM during sample download and isolation 
prior to analysis. 
 We also cannot rule out a gradient of supersaturation during 
the experiment. Sudha and Srinivasan have reported the 
supersaturation dependence of nucleation of Form I and II PCM 
and have shown that nucleation of Form I occurs at relatively 
low supersaturations compared to that of the Form II 
polymorph in aqueous solution.40  In our experiments, we 
would expect a similar behaviour with antisolvent addition 
where there will be a saturation gradient depending on the 
mixing of the solvent and antisolvent. We have tried to mitigate 
this by way of inverting the pressure cell whilst at pressure but, 
as can be observed in Figure 2, the ampoule is not completely 
shattered which would cause a concentration gradient in the 
vessel hence nucleation of different solid forms.  
For the solution concentrations tested in the present work, no 
crystallization was observed in LVP experiments without 
antisolvent addition.  This indicates that the role of the 
antisolvent in these experiments is either to cause 
crystallization upon mixing at 0.8 GPa, or that the reduction in 
solute solubility after mixing allows retention of a pressure-
induced solid form either on compression or decompression.  
Further exploration of the effect of pressure on this system was 
performed in a DAC loaded with solutions of concentration 
0.05, 0.10 and 0.20 g/g solvent mixture.  As with previous 
testing, no nucleation was observed on compression to ca 0.8 
GPa.  Samples were then lowered in pressure and nucleation 
was observed in 0.10 and 0.20 g/g samples on decompression.  
For 0.05 g/g samples, it was found that taking samples to higher 
pressures was required to nucleate a polycrystalline product.  
Single crystals suitable for SC-XRD were obtained in 0.10 and 
0.20 g/g samples upon in-situ nucleation (0.2g/g: Compound 1 
ESI).  For solids precipitated from 0.05 g/g solutions thermal and 
careful pressure cycling was performed to obtain a sample 
suitable for SC-XRD (0.79 GPa, Compound 4 ESI).  In each case, 
the resulting solid was verified, using SC-XRD, as a MeOH 
solvate of PCM – not PCM I or II.  From this point, samples were 
gradually lowered in pressure and monitored by video 
microscopy to determine the solubility point.  One sample for 
each solution concentration was used to obtain an 
approximation of the solubility point (pressure) for the MeOH 
solvate crystal in the respective solutions.  The MeOH solvate 
was seen to dissolve away completely at around 0.2 GPa on 
average. 
During monitoring no evidence of a single crystal-single crystal 
transformation of the MeOH solvate was observed.  During 
solubility determination of the crystal obtained from 0.20 g/g 
solution dissolution was accompanied by nucleation of a new 
crystal (at edge of the gasket) between 0.22-0.19 GPa (Figure 
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S3).  The new crystal was tested by SC-XRD and verified to be 
PCM II (Compound 2 at 0.19 GPa & 3, ambient ESI).  This 
observation identifies an alternative route to obtain PCM II in 
this system.  However, if this route to PCM II occurs in the LVP 
experiment it would infer that anti-solvent addition at ca. 0.8 
GPa leads to precipitation of the MeOH solvate that persists on 
decompression to around 0.21 GPa.  Beyond this solubility 
point, dissolution of the solvate then occurs followed by 
nucleation of PCM II that is now recoverable to ambient 
pressure owing to a reduced solubility of PCM following the 
initial antisolvent addition. 
A new solid Form 
During the accompanying experiments to assess the 
precipitation of PCM from solution in the DAC we did not 
observe the precipitation of the solution to 0.8 GPa. Even with 
heat treatment, precipitation was not observed; this is often 
applied to help initiate precipitation at pressure. On 
decompression, however, we observed the precipitation of a 
solid that was stable to ca. 0.21 GPa before dissolving into 
solution. We were able to obtain a Raman spectrum on the 
precipitant as well as on an annealed single crystal; both of 
these spectra are consistent with one another demonstrating 
the single crystal is representative of the precipitated product. 
Single crystal diffraction data showed that this solid was a 
methanol solvate of paracetamol. The thrust of this study is not 
the identification of new phases or their relationship to each 
other but the process of anti-solvent addition at high pressure. 
Nonetheless, the structure was confirmed for each solution 
used albeit that not all the data were good enough to be 
published. We have reliable structures from crystals grown 
from the 0.05g/g (Rint 8.14%; I/ 17.1; 9738 total reflections) 
and 0.2 g/g (Rint 7.80%; I/ 22.0; 12334 total reflections) 
solutions at ~0.7 GPa. Both of these can be indexed to a larger 
cell (12.9717, 17.1881, 13.0437, 116.032°; P21/n, Z’ = 3) than 
previously observed. The previous cell cannot be identified nor 
can integrations be performed on cells that are close to the 
previous work. The packing of the molecules is very similar to 
the previous structure with a RMS deviation of ~0.55 for the two 
determinations that we have made. There is a slight lateral shift 
in the atomic positions between the two observations. It is 
possible that the addition of water as part of the solvent system 
has played a role in the observation of this phase. Whether the 
difference in the solubility has altered the crystal form or 
whether water plays a role in the crystal structure but at a low 
level remains unsolved and with present technologies it is not 
likely to be solved. Paracetamol does form hydrated structures 
so the latter is not inconceivable where there is interaction with 
water but not in a periodic manner. Unfortunately, these 
observations are only observed during the DAC experiment as 
the large volume press does not possess windows for the 
observation of the solution at high-pressure. We have not 
observed this phase in the product from our antisolvent 
additions at high-pressure which indicates that either, this form 
is not observed at all or that it interconverts to either Form I or 
II of PCM on decompression, which is inferred from the images 
in the supplementary information (Figure S3). 
Conclusions 
In conclusion, we have successfully demonstrated an anti-
solvent addition crystallization of a model pharmaceutical 
compound (paracetamol) at high-pressure conditions.  
Crystallization by this method allowed us to obtain a crystallised 
product at high-pressure and recover the form to ambient 
pressure due to the saturated solution after the antisolvent 
addition. We have also observed during the course of our 
investigation another solid methanol solvate of paracetamol. 
The observation of this new phase was limited to the 
compression of solutions ranging in concentration from 0.05 to 
0.2 g/g  PCM/solvent solution. From the decompression of this 
phase in a Diamond anvil cell it appears that it converts to Form 
II of paracetamol, which is the stable phase at high pressure 
compared with Form I.  It is unclear, and not possible with the 
present experiments, whether the methanol solvate is 
precipitated in the anti-solvent addition experiment or whether 
its observation is limited to the compression of the solvent 
system selected. Nevertheless, we observe that the metastable 
Form II of paracetamol can be recovered through an antisolvent 
addition at high pressure. This experiment demonstrates the 
methodology to enable the access of thermodynamically stable 
forms at high pressure and the potential for them to be 
subsequently recovered to ambient pressure. 
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S1. Large volume press (LVP) 
The LVP used in this work is of the same construction as reported previously.  For antisolvent 
addition, a glass tube was designed to hold the selected antisolvent (water).  The length of the glass 
tube was specific to the target pressure that we wished the tube to break.  Tests were performed to 
measure the contraction of the sample tube as a function of applied load (See Section S4).  The glass 
tube was prepared by flame sealing a standard laboratory glass pipette approximately 25 mm from the 
taper (Figure S1).  After cooling, the remaining piece was cut to the desired size using a ceramic 
cutting blade before filling with deionized water using a syringe and needle.  Once filled, the 
antisolvent tube was sealed using epoxy glue and allowed to fully harden before use in LVP 
experiments.  The length of the resulting sealed tube was verified to be suitable prior to experiment 
after checking of the sealed tube length and the length of the PTFE sample tube.  Prior to use in LVP 
experiment, the glass tube was lightly scored around the diameter of the tube to promote breakage at 
the target pressure. 
 
Figure S1.  Prepared antisolvent glass tube.  Glass tube formed by flame-sealing a laboratory glass pipette and then cutting 
the pulled tip to size before filling and sealing with epoxy glue 
 
S2. UV-vis concentration determination 
Spectra were obtained over the range 200-400 nm and the absorbance at 248 nm used for evaluation 
of PCM concentration.  In order to avoid saturation of the spectrograph detector it was found that 0.2 
g/g solutions required dilution by a factor of 8000 – this dilution factor was applied to all measured 
samples.  A calibration curve was produced using standard samples of PCM dissolved in 64% w/w 
MeOH:H2O with concentrations of 0.14, 0.16, 0.18, 0.20 and 0.22 g/g.  A plot of the calibration curve 
is shown in Figure S2. 
 Figure S2.  Calibration curve obtained for standard PCM solutions prepared in 64% w/w MeOH:H2O.  Dotted line shows 
the linear line of best fit with y-intercept = 0. 
 
The solute concentration in samples following LVP compression were tested by pipetting 5 ul and 
diluting by a factor of 8000 with 64% w/w MeOH:H2O solvent mixture.  3.0 mL of diluted sample 
was transferred to a 10 mm pathlength quartz glass cuvette for UV-vis measurement.  Each sample 
concentration was measured in triplicate and averaged to obtain the mean absorbance for each 
concentration.  A summary of the PCM concentration in the top portion of samples after 
compression/decompression in LVP (without antisolvent addition) is shown in Table S1 
 
 
 
 
 
 
S3. SC-XRD testing 
S3.1 DAC samples 
A Merrill-Basset DAC (600 um culet diamonds) was used with an indented tungsten foil gasket (100 
um thick) that was drilled to prepare a 250 um hole for the sample chamber.  Solution samples were 
loaded along with a small chip of ruby to provide pressure readout by the ruby fluorescence method.1  
Solution samples were taken to approximately 0.8 GPa to achieve comparable pressures to those in 
the LVP experiment.  Crystal nucleation was only observed on decrease of pressure from this point 
(0.10 and 0.20 g/g solution samples) and on the application of further pressure to ca. 1.5 GPa for 0.05 
g/g solution sample.   
Crystals obtained by in-situ nucleation experiments were subject to single crystal X-ray diffraction 
(SC-XRD) to verify the solid form.  Data were collected using a standard run list as shown in Table 
S2. 
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Table S1.  Summary of PCM concentrations in upper layer of solution sample after compression/decompression in large 
volume press experiment determined UV-vis. 
Solution 
concentration  
(g/g solvent) 
Mean 
absorbance  
(248 nm) 
Calculated 
concentration 
(g/g solvent) 
% difference to 
expected 
concentration 
0.14 0.302 0.048 66.0 
0.16 0.446 0.070 56.1 
0.18 0.631 0.099 44.9 
0.20 0.682 0.107 46.4 
0.22 0.973 0.153 30.4 
 Table S2.  Typical data collection strategy used for DAC samples.  Frame exposure time can vary depending on the nature 
(quality/size) of the sample crystal 
Scan 
distance 
(mm) 
2 Theta 
(deg) 
Omega 
(deg) 
Phi 
(deg) Chi (deg) 
Time 
(sec) 
Width 
(deg) 
Sweep 
(deg) direction 
Omega 70 -28 -10 0 54.726 30 0.3 30 negative 
Omega 70 28 40 0 54.726 30 0.3 65 negative 
Omega 70 -28 25 0 -54.726 30 0.3 65 negative 
Omega 70 28 40 0 -54.726 30 0.3 30 negative 
Omega 70 -28 -10 180 54.726 30 0.3 30 negative 
Omega 70 28 40 180 54.726 30 0.3 65 negative 
Omega 70 -28 25 180 -54.726 30 0.3 65 negative 
Omega 70 28 40 180 -54.726 30 0.3 30 negative 
Omega 70 28 40 0 90 30 0.3 52 negative 
Omega 70 -28 29 0 -90 30 0.3 64 negative 
Omega 70 28 40 180 90 30 0.3 52 negative 
Omega 70 -28 29 180 -90 30 0.3 64 negative 
 
Owing to the quality of the in-situ grown crystals, a few runs were sufficient for indexing of crystals.  
Several full collections were performed on samples that were later identified as a PCM:MeOH 
solvate.  Data for these samples were reduced using Bruker, Apex3 software.  Resolved structures 
were solved by intrinsic phasing using SHELXT using Olex2 (v1.2) software.  Full-matrix least-
squares refinement of data was also performed with SHELXL using Olex2 software.  All non-
hydrogen atoms were treated anisotropically for the Form II whilst for the methanol solvate the non-
hydrogen atoms were treated isotropically due to the paucity of data.  Hydrogen atoms were placed on 
the carbon atoms and allowed to ride on their parent atoms. The datasets from the 0.1g/g PCM 
solutions were not of sufficient quality to be deposited in the Cambridge Structural Database but were 
submitted as part of the reviewing process. 
Details of the DAC samples that were tested by SC-XRD are provided in Table S3 and their 
crystallographic information can be found in Table S4. 
Table S3.  Summary of XRD data collection performed for samples in DAC. 
 
 
 
 
Compound Sample Solution 
concentration 
(g PCM / g 
solvent 
mixture) 
Pressure 
(GPa) 
Solid form CCDC code 
 PCM_01gg_201218 0.1 0.76 MeOH:PCM - 
 PCM_01gg_040119 0.1 0.76  MeOH:PCM - 
1 PCM_02gg_070119 0.2 0.71 MeOH:PCM 1902446 
2 PCM_02gg_180119 0.2 0.19 PCM II 1902444 
3 PCM_02gg_ambient 0.2 Ambient PCM II 1902442 
4 PCM_005gg_250119 0.05 0.79 MeOH:PCM 1902445 
Table S4: Crystallographic information for the five datasets taken at various solution concentrations and pressures. Dataset 
1 crystallised from a 0.2 g/g paracetamol to methanol:water (64% w/w) solution at 0.72 GPa. Dataset 2 was performed on a 
crystal isolated from same loading as 1 but reduced in pressure to 0.21 GPa. The crystal grew from solution (FigureS3) 
after leaving the sample. Dataset 3 was the same crystal as dataset 2 but at ambient pressure. Dataset 4 was taken on a 
crystal isolated from a 0.05 g/g paracetamol to methanol:water (64% w/w) solution at 0.75 GPa. Dataset 5 was taken on a 
crystal at ambient pressure recovered from the large volume press.  
 (1) (2) (3) (4) (5) 
Crystal data 
Chemical formula CH4O·C8H9NO2 C8H9NO2 C8H9NO2 CH4O·C8H9NO2 C8H9NO2 
Mr 183.20 151.16 151.16 183.20 151.16 
Crystal system, 
space group 
Monoclinic, P21/n Orthorhombic, 
Pbca 
Orthorhombic, 
Pbca 
Monoclinic, 
P21/n 
Orthorhombic, 
Pbca 
Temperature (K) 293 296 296 293 296 
Pressure (GPa) 0.72 0.21  Ambient 0.75 Ambient 
a, b, c (Å) 13.0234 (15), 17.2078 
(9), 13.0925 (15) 
17.1202 (17), 
11.7968 (11), 
7.288 (2) 
17.143 (8), 
11.806 (6), 7.399 
(10) 
12.9717 (15), 
17.1881 (9), 
13.0437 (19) 
17.1522 (5), 
11.8201 (4), 
7.3985 (2) 
, ,  (°) 90, 116.209 (7), 90 90, 90, 90 90, 90, 90 90, 116.032 (8), 
90 
90, 90, 90 
V (Å3) 2632.4 (5) 1471.9 (5) 1497 (2) 2613.2 (5) 1499.98 (8) 
Z 12 8 8 12 8 
Radiation type Mo K Mo K Mo K Mo K Cu K 
 (mm-1) 0.10 0.10 0.10 0.11 0.80 
Crystal size (mm) 0.15 × 0.14 × 0.05 0.09 × 0.07 × 
0.05 
0.09 × 0.07 × 
0.05 
0.18 × 0.06 × 
0.05 
0.2 × 0.18 × 0.05 
Data collection 
Diffractometer Bruker APEX-II CCD Bruker APEX-II 
CCD 
Bruker APEX-II 
CCD 
Bruker SMART 
APEX2 area 
detector 
Bruker APEX-II 
CCD 
Absorption 
correction 
Multi-scan  
SADABS2016/2 
(Bruker,2016/2) was 
used for absorption 
correction. wR2(int) 
was 0.1071 before and 
0.0616 after 
correction. The Ratio 
of minimum to 
maximum 
transmission is 
0.8490. The /2 
correction factor is 
Not present. 
Multi-scan  
SADABS2016/2 
(Bruker,2016/2) 
was used for 
absorption 
correction. 
wR2(int) was 
0.1466 before 
and 0.0755 after 
correction. The 
Ratio of 
minimum to 
maximum 
transmission is 
0.8510. The /2 
correction factor 
is Not present. 
Multi-scan  
SADABS2016/2 
(Bruker,2016/2) 
was used for 
absorption 
correction. 
wR2(int) was 
0.0969 before 
and 0.0605 after 
correction. The 
Ratio of 
minimum to 
maximum 
transmission is 
0.7071. The /2 
correction factor 
is Not present. 
Multi-scan  
SADABS2016/2 
(Bruker,2016/2) 
was used for 
absorption 
correction. 
wR2(int) was 
0.0848 before 
and 0.0556 after 
correction. The 
Ratio of 
minimum to 
maximum 
transmission is 
0.9145. The /2 
correction factor 
is Not present. 
Multi-scan  
SADABS2016/2 
(Bruker,2016/2) 
was used for 
absorption 
correction. 
wR2(int) was 
0.0894 before 
and 0.0482 after 
correction. The 
Ratio of 
minimum to 
maximum 
transmission is 
0.8688. The /2 
correction factor 
is Not present. 
 Tmin, Tmax 0.632, 0.745 0.634, 0.745 0.527, 0.745 0.681, 0.745 0.654, 0.753 
No. of measured, 
independent and 
 observed [I > 
12022, 1214, 819   4019, 413, 271   866, 304, 161   9591, 1319, 765   15062, 1378, 
1223   
2(I)] reflections 
Rint 0.078 0.118 0.129 0.081 0.038 
max (°) 23.3 23.3 23.4 23.3 68.3 
(sin /)max (Å-1) 0.556 0.557 0.558 0.556 0.603 
Refinement 
R[F2 > 2(F2)], 
wR(F2), S 
0.094,  0.272,  1.07 0.058,  0.147,  
1.08 
0.068,  0.207,  
1.08 
0.129,  0.417,  
1.55 
0.045,  0.122,  
1.07 
No. of reflections 1214 413 304 1319 1378 
No. of parameters 130 90 90 130 91 
No. of restraints 0 75 75 0 75 
max, min (e Å-
3) 
0.31, -0.23 0.13, -0.15 0.14, -0.13 0.56, -0.36 0.30, -0.18 
 
S3.2 Ambient pressure PCM II 
Following LVP experiments, the sample material recovered was tested by SC-XRD to verify its 
contents.  Crystals were dispersed in silicone oil and mounted on a low-background Kapton microloop 
(200 µm).  Data was collected on a Bruker D8 Venture diffractometer equipped with a Photon 100 
detector.  Crystals were indexed in order to assess their solid form, in order to do this a ‘fast scan’ 
experimental method was employed.  This method is also used for screening crystals ahead of 
determining the strategy for a full collection for structural solution. 
A full collection was performed on a particle of PCM II in order to assess the quality of the 
crystallized material.  A summary of the collected data is shown in Error! Reference source not 
found. Compound 5. 
S4. Axial compression measurement 
For large volume press antisolvent experiments it was necessary to establish the resulting length of the 
PTFE tube as a function of pressure.  This would in turn allow us to produce a glass tube of suitable 
length such that it breaks at the target pressure (internal length of the PTFE sample tube).  Contraction 
of the sample tube was monitored by video microscopy during compression of 2 solvent systems – 
water and methanol:water (64% w/w). 
PTFE sample tubes were assembled as per normal procedures and filled only with the chosen solvent 
before capping and assembling in the copper beryllium cell.  Sample pressure is generated by use of a 
pneumatic actuator to apply load to the top of the sample tube.  A camera (Basler acA1920—40uc) 
and zoom lens was used to image the actuator and to monitor its translation as a function of applied 
load.  Still images were obtained at each pressure point and analysed using ImageJ to calculate the 
translation of the actuator. 
S5. Video monitoring 
Video monitoring of DAC samples was performed using solution concentrations of 0.05, 0.10 and 
0.20 g/g PCM/solvent mixture.  Solution samples were loaded in a DAC for compression and 
decompression studies.  Video microscope was used to monitor crystallized material during 
decompression to aid identification of the dissolution point of the crystalline phase 
S5.1 Dissolution point monitoring 
Once a sample had nucleated and a suitable crystal was obtained the sample pressure was gradually 
decreased and monitored at each point by video microscopy.  Sample pressure was established by the 
ruby fluorescence technique using an Almax Optiprexx PLS spectrometer equipped with a 532 nm 
excitation laser (20 mW).  At each pressure point the sample would be monitored over at least a 30 
minute period with images recorded every minute.  For longer monitoring periods (over night or 
weekend during experiments) a 5 minute or 30 minute interval would be used. 
Table S4.  Summary of dissolution points (pressure) recorded for PCM:MeOH solvate in solutions of 0.05, 0.10 and 0.20 g/g 
concentration in 64% w/w MeOH:H2O solvent mixture.   
 
 
 
 
For each sample concentration the pressure at which the crystal completely dissolved was recorded.  
Only one sample was used for this determination for each of the solution concentrations, the obtained 
solubility points are summarized in Table S4. 
 
S5.2 Nucleation of PCM II 
During monitoring of the 0.2 g/g sample dissolution of a MeOH solvate crystal (verified by SC-XRD) 
was observed and simultaneously nucleation of a crystal at the gasket edge was observed.  This 
process is summarized in Figure S3a-d that shows frames during the transformation over a 4-hour 
period.  The nucleated crystal was subsequently identified as PCM II by SC-XRD (Table S4; 2) 
Solution 
Concentration 
(g/g solvent) 
Lowest pressure 
crystal observed 
(GPa) 
Highest pressure 
solution phase 
(GPa) 
0.05 0.30 0.26 
0.10 0.14 0.13 
0.20 0.22 0.19 
PCM II 
PCM:MeOH solvate 
Figure S3.  Still images taken from video monitoring of MeOH solvate in 0.2 g/g solution at ca. 0.21 GPa.  The consecutive 
frames are recorded every 30 minutes and show the dissolution of PCM:MeOH and the nucleation and growth of a new 
crystal subsequently identified as PCM II by SC-XRD (compound 2).  The scale bar in the image represents 100 µm. 
(a) (b) 
(c) (d) 
100 µm 
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Table labelling corrected 
S5.3 Solution mediated transformation (PCM II -> I) 
Following a LVP antisolvent addition experiment, sample was taken immediately for monitoring 
using a Leica DM6000M microscope.  Solids were not isolated from the supernatant but were left in 
the mother liquor to monitor for suspected solution mediated phase transformation.  The sample was 
monitored over a 30 minute period with an image recorded every 60 seconds.  The recorded images 
show dissolution of PCM II (needles) and simultaneous growth and nucleation of PCM I (blocks), 
Figure S4. An animated version of this timelapse, which show the transformation more clearly, are 
available in the ESI for this paper.  
 
  
Figure S4.  The first and last image recorded during a 30 minute monitoring period of the sample material obtained from 
LVP experiment.  The particles were not isolated from the supernatant, but remain in contact with the solution phase.  
Images were recorded every 60 seconds and show the rapid dissolution of PCM II particles (rods) and growth of PCM I 
(blocks).  The scale bar represents 1 mm.  Dissolution of PCMII particles has been highlighted (white circle) 
S6. X-ray powder diffraction 
XRPD data was collected on samples isolated after LVP antisolvent addition experiment.  The same 
sample was repeatedly collected 5 times over 3 hours (approx. 35 min/collection).  The XRPD 
patterns obtained in this test are shown in Figure S5.  The patterns show no change with time and 
indicate that after isolation from the supernatant, no further solid form change occurs (over a 
monitoring period on XRPD of ca 3 hours).  
 
Figure S5.  XRPD patterns obtained from the same sample after isolation from the supernatant following LVP experiment.  
Each pattern was recorded over a 35 minute period and no change in pattern is observed. 
The same sample was then collected over a longer period (7 hours) to obtain a pattern with improved 
signal:background for Rietveld refinement.  The XRPD pattern obtained is shown in Figure S6.  This 
pattern is again unchanged from the pattern first obtained after isolation of the sample and therefore 
demonstrates that the isolated sample remains unchanged for at least 10 hours once removed from the 
supernatant.   
With a view to investigating the role of solution mediated transformation of PCM II  PCM I, the 
LVP anti-solvent addition experiment was performed with 0.5 mL of perfluorinated oil 
(Perfluoropolyether fluid, Galden SV110, Solvay, Italy) in the sample tube.  The aim of this was to 
establish if precipitated particles could be ‘protected’ from the solution phase by being trapped in or 
by being coated by the hydrophobic oil phase.  Solids isolated from this test were tested by XRPD, the 
obtained pattern is shown in Figure S6. 
 Figure S6.  XRPD patterns obtained from samples produced by LVP experiment with (upper, red) and without (lower, green) 
inclusion of 500 µl perfluorinated oil.  Subtle difference in the patterns indicate differences in the relative amounts of PCM I 
and II in the sample mixtures. 
Analysis of the patterns by Rietveld refinement (performed using Topas 5.0 academic version2) show 
an increased proportion of PCM II in the test performed using oil.  Reference structures for PCM I 
and II were retrieved from the CSD database3 (HXACAN044 and HXACAN085) and used for 
refinement.  Plots showing the output of Rietveld refinement for samples obtained without and with 
oil in LVP experiment are shown in Figure S7 and Figure S8, respectively. 
 
Figure S7. Results plot from Rietveld refinement of XRPD data obtained in LVP experiment without use of perfluorinated 
oil.  Rietveld refinement indicates ca. 58 % content of PCM II in the sample mixture.  Experimental data is represented by 
the black line, fitted data shown by the red line and the difference shown in blue.  Green and grey tick marks represent 
reflections attributed to PCM forms I and II, respectively. 
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Figure S8. Results plot from Rietveld refinement of XRPD data obtained in LVP experiment without use of perfluorinated 
oil.  Rietveld refinement indicates ca. 65 % content of PCM II in the sample mixture.  Experimental data is represented by 
the black line, fitted data shown by the red line and the difference shown in blue.  Green and grey tick marks represent 
reflections attributed to PCM forms I and II, respectively. 
S7. Raman spectra, MeOH solvate 
As part of characterization of the identified MeOH solvate of PCM, Raman spectrum was collected of 
the crystal obtained from 0.05 g/g solvent mixture (64:36 w/w, MeOH:H2O).  The recorded spectrum 
is shown in Figure S9. 
 
Figure S9.  Raman spectrum obtained from MeOH solvate of PCM obtained from 0.05 g/g solvent mixture solution at 0.2 
GPa in diamond anvil cell.  Peak at approx. 1330 cm-1, marked with asterisk, attributed to diamond.  
  
5 10 15 20 25 30 35
A
rb
 I
n
t.
2 Theta (°)
References: 
 
1 G. J. Piermarini, S. Block, J. D. Barnett and R. A. Forman, J. Appl. Phys., 1975, 46, 2774–2780. 
2 A. Coelho, TOPAS – Acad. Gen. Profile Struct. Anal. Softw. Powder Diffr. Data, 2012. 
3 C. R. Groom, I. J. Bruno, M. P. Lightfoot and S. C. Ward, Acta Crystallogr. Sect. B, 2016, 72, 171–179. 
4 D. Y. Naumov, M. A. Vasilchenko, J. A. K. Howard and IUCr, Acta Crystallogr. Sect. C Cryst. Struct. 
Commun., 1998, 54, 653–655. 
5 G. Nichols and C. S. Frampton, J. Pharm. Sci., 1998, 87, 684–693. 
 
